Tenmile — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system.
BiotechDigital HealthHealthtechMedical DevicesAdelaide, AU
Simon Barry(Chief Medical Scientist)inDr Deborah Rathjen(Chief Executive Officer & Managing Director)Professor Shaun McColl(Chief Scientific Officer)
BoardClaudine Bonder(Head, Vascular Biology and Cell Trafficking Laboratory)
CurveBeam AI develops point-of-care cone beam CT imaging systems combined with AI and deep learning tools for orthopedic and bone health applications, including fragility fracture prevention.
AI & Machine LearningBiotechHardwareHealthtechMedical DevicesHatfield, US
BoardGregory Brown(Director)David Seeman(Director)Waradana Malitha Hashan De Silva(Director)Robert Lilley(Director)
Co-investorskineo finance
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



